Insights
Condense – the world’s first company to deliver the power, connection and immersiveness of live, real-world events into the metaverse – has raised a $4.5 million round led by LocalGlobe, 7percent Ventures and Deeptech Labs alongside angel investors. Condense was founded in 2019 and joined SETsquared Bristol in March 2021. It is the only company in…
Read More
Channel 4 is partnering with our member Gritty Talent to help independent production companies build more diverse senior teams. Gritty Talent, who won our 2022 Breakthrough Bursary, is a trailblazing company bridging TV, talent and technology, who discover, nurture and connect talented people from under-represented groups into the media industry. In 2021 the startup, founded…
Read More
Following our member Radii Devices‘ recent grant funding success with Innovate UK’s Biomedical Catalyst fund, we had a chat with Founder and CEO, Joshua Steer, to find out about his journey from researcher to medtech startup… Radii Devices key facts Start date: April 2020 Market sector: Medtech Location: Engine Shed, Bristol Number of employees: 6 Company growth status: About…
Read More
Our member company and University of Bristol spin-out, Zentraxa, has raised capital investment from Future Planet Capital, BPEC and Science Angel Syndicate to develop their innovative Zentide platform for engineering bespoke biomaterials. With generous support of their recently awarded Innovate UK grant, Zentraxa is rapidly moving towards contracted commercial concept development in both medical adhesives…
Read More
Our alumni member, Neighbourly, the community investment and engagement platform, is moving into our SETsquared Bristol home, Engine Shed, following another successful funding round of £1.6 million led by Guinness Ventures. This latest funding round takes the total investment raised to date by the company to £8m ($10m). The investment will help further expand the…
Read More
Our member GenomeKey, has secured an Innovate UK Biomedical Catalyst research award of £950,000 towards faster diagnosis and treatment of sepsis, one of the world’s most deadly diseases. The funding will enable the Bristol-based research and development company to provide rapid bacterial species identification and antimicrobial profiling in the hospital, which will save lives, save money,…
Read More
Dr. Carey McClellan, CEO of our member company getUBetter, has been invited to join the prestigious NHS Innovation Accelerator (NIA) as a Fellow. NIA was established in 2020 to support exceptional individuals to scale promising innovations across England’s NHS. getUBetter has experienced significant growth over the last 12 months and is now providing its digital self-management…
Read More
Our member and University of Bristol spin-out FluoretiQ, the award-winning medical devices company, has announced a new initiative in its fight against antimicrobial resistance (AMR). According to a recent Lancet report, AMR isn’t a pandemic in waiting, its already here. AMR infections are estimated to cause 700,000 deaths each year globally. That figure is predicted to…
Read More
Our member and University of Bristol spin-out, Lineat Composites, has successfully raised significant funds through their initial seed round of investment, bringing their total investment to date to over £1 million. Lineat Composites results from several years of EPSRC funded research by the academic team at the university’s Bristol Composites Institute. This included the development of…
Read More
Our alumnus Neighbourly, the community engagement and investment platform, has been awarded a 2022 Queen’s Award for Enterprise in the Innovation category. Now in its 56th year, the Queen’s Awards for Enterprise are the most prestigious business awards in the country – with the innovation category recognising businesses that demonstrate strong commercially successful innovative products…
Read More